Global Harmonization Task Force Meeting In Brief
This article was originally published in The Gray Sheet
Executive Summary
Asian Harmonization: Members of the Asian Harmonization Working Party, whose 16 economies include China, Indonesia and Korea and will soon include India, have agreed that if a product is approved after submission of one common government dossier, it will receive approval in other member countries, said Mukundan Sugundan Pillay, AHWP chair and deputy director general of health, research and technical support in the Malaysian Ministry of Health, Oct. 3 at the Global Harmonization Task Force conference in Washington, D.C. "We are also working on the principle of not reinventing the wheel, because if FDA has spent so much money evaluating a device, I'm not going to look at it - I'll approve it in 24 hours," he added
You may also be interested in...
Global Harmonization Task Force Moves Into “Implementation Mode”
Efforts to harmonize device regulations globally will see more activity over the next year if Larry Kessler has his way
IPO Year In Review: Record-Year Bodes Well For 2021, And For More SPACs
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott Capitalizes On Pandemic Testing Boom; Device Sales Stay Almost Flat
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: